CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE7203.10219.25 (+3.14 %)
PREV CLOSE () 6983.85
OPEN PRICE () 6995.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2848
TODAY'S LOW / HIGH ()6918.65 7269.40
52 WK LOW / HIGH ()2006 7794
NSE7198.10224.7 (+3.22 %)
PREV CLOSE() 6973.40
OPEN PRICE () 6973.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 7198.10 (122)
VOLUME 18858
TODAY'S LOW / HIGH() 6940.00 7274.15
52 WK LOW / HIGH ()2009.05 7790
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone : 040-67611600 / 67611700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
03Apr Neuland Laboratories informs about cer
Neuland Laboratories has informed that it enclosed certificate as requir..
03Apr Neuland Laboratories informs about cer
Neuland Laboratories has informed that it enclosed certificate as requir..
04Mar Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Company’s management will be..
26Feb Neuland Laboratories informs about iss
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Di..
13Nov Neuland Laboratories informs about tra
Neuland Laboratories has informed that it enclosed the transcript of the..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit807.011631.19
Gross Profit 1037.8 2152.13
Operating Profit 1226.652810.56
Net Sales 3928.2811911.98
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26277.60 (1.60%)
M.Cap ( in Cr)
55838.07
Astrazeneca Pharma I (BSE)
 5556.10 (2.60%)
M.Cap ( in Cr)
13890.25
Medicamen Biotech (BSE)
 589.55 (20.00%)
M.Cap ( in Cr)
749.59
Fredun Pharma (BSE)
 934.45 (10.49%)
M.Cap ( in Cr)
441.22
Bharat Parenterals (BSE)
 1791.20 (5.00%)
M.Cap ( in Cr)
1042.42
Shareholding Pattern
NON-INSTITUTION 35.88%
PROMOTERS 32.74%
MUTUAL FUNDS/UTI 3.88%
GOVERNMENT 0.4%
FI/BANKS/INSURANCE 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74671.28941.12 (1.28%)
NIFTY22643.40223.45 (1.00%)
Dow Jones 38239.66153.86 (0.40%)
Nasdaq 15927.90316.14 (2.03%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI